Latest Articles and Analysis

DoxyPEP post-exposure prophylaxis demonstrates effectiveness for STI prevention with implementation challenges and equity concerns.

Insurance companies deploy AI algorithms for automated prior authorization denials, restricting patient access to prescribed treatments.

Pragmatic approach to healthcare policy reform requires accepting incremental progress while maintaining advocacy commitment.

Reflection on advocacy values and health equity commitment during political transitions.

Healthcare policy opportunities and threats during lame duck congressional session.

CDC progress data on STI and overdose prevention initiatives shows mixed results.

World AIDS Day reflection on ending the HIV epidemic: challenges and opportunities.

Bipartisan HCV elimination legislation analysis and critical legislative window.

Partisan political battles threaten essential public health programs and HIV funding.

Pugh reflects on 340B policy and patient advocacy in ensuring equitable medication access.

Q4 2024 Watch: HCV treatment access assessment with guidance for disaster-displaced individuals.

Proposed Cigna-Humana merger implications for healthcare competition and access.

Call to action for community input on federal health policy initiatives.

Federal policy failures on copay accumulator programs restrict patient assistance benefits.

FTC complaint against major PBMs for anticompetitive rebating and insulin pricing.

Medicaid disenrollment during pandemic unwinding and impacts on vulnerable populations.

Gamification as innovative approach to HIV prevention education for youth.

Critical role of mental health services in HIV treatment and epidemic control.

Barriers to PrEP access for minors in Southern states: legal and political obstacles.

Data gaps in HIV surveillance for transgender people and policy implications.